CACI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient entry: price (~$620 pre-market) is below the key pivot ($641) with weakening momentum (MACD negative and expanding), increasing the odds of a near-term dip toward support ($611).", "Longer-term backdrop remains constructive (most analysts raising targets; Q2 FY2026 growth solid), but near-term positioning signals (heavy insider + hedge fund selling, put-heavy option volume) argue against chasing immediately.", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: No signal on given stock today.\n- SwingMax: No signal on given stock today."]
["Trend structure: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) suggests the bigger-picture trend is still up.", "Momentum: MACD histogram -2.931 (below 0 and negatively expanding) = downside momentum building short-term.", "RSI(6) 43.18 = neutral-to-weak (not oversold), leaving room for further downside before a technical bounce becomes compelling.", "Key levels: Pivot 641.15 (overhead), Support S1 611.16 then S2 592.63; Resistance R1 671.13.", "Near-term pattern read: probability model implies muted returns (roughly flat next day/week, slightly positive next month), consistent with consolidation rather than an immediate breakout."]
with Buy/Overweight bias, implying continued confidence in multi-year defense/national security spend tailwinds.", "Business narrative tailwind: described as a capital-light beneficiary of higher U.S. national security budgets; positive framing around funding/ramp opportunities.", "Reputation/brand: named a Fortune World's Most Admired Company (9th consecutive year), supportive for talent retention and customer confidence."]
suggests near-term hedging/speculation skewed bearish.", "Profitability mix: gross margin down 2.04% YoY despite earnings growth, a watch item if it persists."]
["Latest quarter (2026/Q2): Revenue $2.220B (+5.73% YoY), Net Income $123.9M (+12.66% YoY), EPS $5.59 (+14.55% YoY) \u2014 healthy growth with earnings outpacing revenue.", "Margin: Gross margin 30.23% (down 2.04% YoY) \u2014 indicates some cost/mix pressure even as bottom-line expanded."]
["Trend: predominantly positive and getting more optimistic \u2014 several firms raised price targets in January-February 2026 while reiterating Buy/Overweight (UBS, Truist, Stifel, JPM).", "Key dissent: Citi remains Neutral (though it raised its target to $721), implying valuation/upside may be more balanced versus peers in its view.", "Wall Street pros: strong positioning for defense/national security spending; expectation of faster growth and funding-driven ramps.", "Wall Street cons: at least one major firm stays Neutral; near-term execution/margin mix and the stock\u2019s near-term technical setup can limit immediate upside."]
